"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
NCT02957630
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
101
Enrollment
INDUSTRY
Sponsor class
Conditions
Contraception
Liver Metabolism
Hemostasis Parameter
Interventions
DRUG:
15 mg E4/3 mg DRSP
DRUG:
30 mcg EE/150 mcg LNG
DRUG:
20 mcg EE/3 mg DRSP
Sponsor
Estetra